MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to generate...
-$69,195K
Net loss
attributable to generate...
-$61,446K
Convertible preferred stock
accrued dividends
$7,749K
Net loss
attributable to...
-$268K
Net loss
-$61,714K
Interest income
$2,913K
Foreign currency
exchange loss
$58K
Loss before
provision for income taxes
-$61,686K
Provision for income taxes
$28K
Total other income
(expense), net
$2,426K
Change in fair value of
convertible preferred stock...
$363K
Interest expense
$182K
Loss from operations
-$64,112K
Collaboration revenue
$7,224K
Total operating
expenses
$71,336K
Research and development
$57,812K
General and
administrative
$13,524K
Back
Back
Income Statement
Generate Biomedicines, Inc. (GENB)
Generate Biomedicines, Inc. (GENB)
source: myfinsight.com